Market Closed -
Nyse
04:00:02 2024-05-17 pm EDT
|
5-day change
|
1st Jan Change
|
5.41
USD
|
-3.05%
|
|
+4.24%
|
-56.89%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
10,629
|
6,647
|
5,096
|
2,225
|
-
|
-
|
Enterprise Value (EV)
1 |
9,637
|
6,194
|
5,027
|
2,038
|
2,020
|
2,082
|
P/E ratio
|
-24.8
x
|
-62.1
x
|
-19.6
x
|
-15.4
x
|
-37.6
x
|
-43.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.8
x
|
2.45
x
|
1.18
x
|
0.36
x
|
0.29
x
|
0.24
x
|
EV / Revenue
|
5.26
x
|
2.29
x
|
1.16
x
|
0.33
x
|
0.26
x
|
0.23
x
|
EV / EBITDA
|
-250
x
|
1,457
x
|
-52.9
x
|
-49.3
x
|
63.7
x
|
23.7
x
|
EV / FCF
|
-62.3
x
|
-42.4
x
|
-29.2
x
|
17.5
x
|
-215
x
|
397
x
|
FCF Yield
|
-1.61%
|
-2.36%
|
-3.42%
|
5.72%
|
-0.47%
|
0.25%
|
Price to Book
|
9.89
x
|
6.39
x
|
7.82
x
|
3.76
x
|
3.82
x
|
-
|
Nbr of stocks (in thousands)
|
393,655
|
411,855
|
406,041
|
411,262
|
-
|
-
|
Reference price
2 |
27.00
|
16.14
|
12.55
|
5.410
|
5.410
|
5.410
|
Announcement Date
|
3/3/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,218
|
1,834
|
2,708
|
4,316
|
6,166
|
7,626
|
9,152
|
EBITDA
1 |
-
|
-38.62
|
4.251
|
-95
|
-41.38
|
31.71
|
87.79
|
EBIT
1 |
-
|
-394
|
-120.4
|
-231.9
|
-165.4
|
-101.8
|
-93.49
|
Operating Margin
|
-
|
-21.49%
|
-4.45%
|
-5.37%
|
-2.68%
|
-1.33%
|
-1.02%
|
Earnings before Tax (EBT)
1 |
-
|
-404.6
|
-105.7
|
-194.5
|
-146.5
|
-35.71
|
-39.67
|
Net income
1 |
-60.05
|
-406.5
|
-106.6
|
-262.6
|
-142.4
|
-60.48
|
-30.18
|
Net margin
|
-4.93%
|
-22.17%
|
-3.93%
|
-6.08%
|
-2.31%
|
-0.79%
|
-0.33%
|
EPS
2 |
-19.54
|
-1.090
|
-0.2600
|
-0.6400
|
-0.3507
|
-0.1440
|
-0.1232
|
Free Cash Flow
1 |
-
|
-154.7
|
-146.2
|
-172
|
116.6
|
-9.411
|
5.25
|
FCF margin
|
-
|
-8.44%
|
-5.4%
|
-3.99%
|
1.89%
|
-0.12%
|
0.06%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
5.98%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/21
|
3/3/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
462.9
|
653.4
|
670.1
|
694.9
|
689.8
|
1,136
|
1,149
|
1,216
|
1,056
|
1,604
|
1,559
|
1,538
|
1,465
|
2,020
|
1,965
|
EBITDA
1 |
-26.69
|
12.03
|
7.496
|
-4.653
|
-10.62
|
23.86
|
10.26
|
-5.777
|
-137.1
|
29.05
|
-6.611
|
-17.88
|
-43.99
|
56.54
|
21.4
|
EBIT
1 |
-47.87
|
-0.743
|
-21.05
|
-29.52
|
-69.12
|
6.261
|
-29.82
|
-48.97
|
-164.3
|
-7.178
|
-36.97
|
-53.06
|
-71.57
|
19.2
|
-16.4
|
Operating Margin
|
-10.34%
|
-0.11%
|
-3.14%
|
-4.25%
|
-10.02%
|
0.55%
|
-2.6%
|
-4.03%
|
-15.56%
|
-0.45%
|
-2.37%
|
-3.45%
|
-4.89%
|
0.95%
|
-0.83%
|
Earnings before Tax (EBT)
1 |
-57.25
|
0.655
|
-20.46
|
-29.94
|
-55.94
|
14.2
|
-15.72
|
-30.27
|
-166.9
|
3.114
|
-35.57
|
-38.15
|
-75.02
|
42.92
|
-3.56
|
Net income
1 |
-56.72
|
1.23
|
-20.65
|
-30.67
|
-56.47
|
16.02
|
-16.75
|
-31.44
|
-230.4
|
-6.064
|
-33.34
|
-39.56
|
-69.81
|
35.33
|
-9.18
|
Net margin
|
-12.25%
|
0.19%
|
-3.08%
|
-4.41%
|
-8.19%
|
1.41%
|
-1.46%
|
-2.59%
|
-21.82%
|
-0.38%
|
-2.14%
|
-2.57%
|
-4.77%
|
1.75%
|
-0.47%
|
EPS
2 |
-0.1400
|
0.002900
|
-0.0500
|
-0.0700
|
-0.1400
|
0.0376
|
-0.0400
|
-0.0800
|
-0.5700
|
-0.0148
|
-0.0813
|
-0.0977
|
-0.1700
|
0.0798
|
-0.0233
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/22
|
5/5/22
|
8/4/22
|
11/3/22
|
3/1/23
|
5/9/23
|
8/3/23
|
11/2/23
|
2/27/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
992
|
454
|
69
|
187
|
205
|
143
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-155
|
-146
|
-172
|
117
|
-9.41
|
5.25
|
ROE (net income / shareholders' equity)
|
-
|
-101%
|
-9.99%
|
-30.8%
|
-27.8%
|
-10.7%
|
-7.88%
|
ROA (Net income/ Total Assets)
|
-
|
-40%
|
-6.49%
|
-15.3%
|
-11.5%
|
-2.39%
|
-
|
Assets
1 |
-
|
1,016
|
1,642
|
1,719
|
1,244
|
2,528
|
-
|
Book Value Per Share
2 |
-
|
2.730
|
2.520
|
1.600
|
1.440
|
1.420
|
-
|
Cash Flow per Share
2 |
-
|
-0.4000
|
-0.3200
|
-0.3800
|
0
|
0.0900
|
-
|
Capex
1 |
-
|
6.56
|
15.4
|
15.8
|
18.9
|
23.5
|
20
|
Capex / Sales
|
-
|
0.36%
|
0.57%
|
0.37%
|
0.31%
|
0.31%
|
0.22%
|
Announcement Date
|
3/18/21
|
3/3/22
|
3/1/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
5.41
USD Average target price
8.053
USD Spread / Average Target +48.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -56.89% | 2.22B | | -20.57% | 2.95B | | -16.01% | 2.84B | | -37.78% | 268M | | +5.57% | 235M | | -40.04% | 196M | | -36.31% | 110M |
Doctor's Office
|